Inhibition of endogenous H<sub>2</sub>S production suppresses the viability of multiple myeloma cells: application of carbidopa and benserazide capable of inhibiting cystathionine-β-synthase to treatment of bortezomib-resistant multiple myeloma
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.